Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jun 17, 2013
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock
2013-06-04+26,110→ 488,798 total
Footnotes (1)
- [F1]The shares acquired were issued for the account of the reporting person at a value of $2.60 per share in payment of contingent value rights held by the reporting person.